Cargando…

The Therapeutic Landscape of Salivary Gland Malignancies—Where Are We Now?

Salivary gland malignancies (SGMs) account for less than 5% of new diagnoses in head and neck tumors. If feasible, surgery is the preferred treatment modality. Nevertheless, some malignancies have a tendency of recurrence, with possible distant metastasis. Alternative treatment strategies, such as p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cleymaet, Robbert, Vermassen, Tijl, Coopman, Renaat, Vermeersch, Hubert, De Keukeleire, Stijn, Rottey, Sylvie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9740091/ https://www.ncbi.nlm.nih.gov/pubmed/36499216 http://dx.doi.org/10.3390/ijms232314891

Ejemplares similares

A Tissue Section-Based Near-Infrared Spectroscopical Analysis of Salivary Gland Tumors
por: Coopman, Renaat, et al.
Publicado: (2021)

Prognostic Features of Near-Infrared Spectroscopy Following Primary Radical Prostatectomy
por: Vermassen, Tijl, et al.
Publicado: (2021)

Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives
por: De Keukeleire, Stijn J., et al.
Publicado: (2021)

Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?
por: Almangush, Alhadi, et al.
Publicado: (2022)

Concordance, Correlation, and Clinical Impact of Standardized PD-L1 and TIL Scoring in SCCHN
por: De Keukeleire, Stijn Jeroen, et al.
Publicado: (2022)

An open‐label, nonrandomized, phase Ib feasibility study of cusatuzumab in patients with nasopharyngeal carcinoma
por: De Meulenaere, Astrid, et al.
Publicado: (2021)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Where are we now?
Publicado: (1977)

A review of the treatment landscape in paroxysmal nocturnal haemoglobinuria: where are we now and where are we going?
por: Griffin, Morag, et al.
Publicado: (2020)

Labial salivary gland biopsy and secondary Sjögren’s syndrome: where we are and where we want to be
por: Manzo, Ciro
Publicado: (2019)

Pim kinases in hematological malignancies: where are we now and where are we going?
por: Mondello, Patrizia, et al.
Publicado: (2014)

Perineural Invasion in Adenoid Cystic Carcinoma of the Salivary Glands: Where We Are and Where We Need to Go
por: Liu, Xiaohao, et al.
Publicado: (2020)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Bibliometric Analysis of Global Research Landscape and Hotspots on Dysmenorrhea: Where are We Now?
por: Liu, Zhihui, et al.
Publicado: (2023)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Aromatase inhibitors--where are we now?
por: Miller, W. R.
Publicado: (1996)

Depression research: where are we now?
por: Lee, Saebom, et al.
Publicado: (2010)

Personal workstations: Where are we now?
por: Willers, Ian Malcolm
Publicado: (1982)

Personal genomics: Where are we now?
por: Angrist, Misha
Publicado: (2016)

9. GFR - Where are We Now?
por: Delanghe, Joris R.
Publicado: (2009)

Calcaneal fractures: Where are we now?
por: Razik, Aisha, et al.
Publicado: (2017)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Mindfulness in psychiatry – where are we now?
por: Groves, Paramabandhu
Publicado: (2016)

MHC Restriction: Where Are We Now?
por: Zareie, Pirooz, et al.
Publicado: (2020)

Microbiota and Obesity: Where Are We Now?
por: Ballini, Andrea, et al.
Publicado: (2020)

Pegfilgrastim Biosimilars: Where Are We Now?
por: Selby, Christopher, et al.
Publicado: (2021)

Hepatocellular adenoma: Where are we now?
por: Wang, Xi, et al.
Publicado: (2022)

Osteopontin and Transplantation: Where Are We Now?
por: Kaleta, Beata
Publicado: (2021)

Epilepsy and psychosis– where are we now?
por: Pereira, I., et al.
Publicado: (2021)

Tuberculosis elimination: where are we now?
por: Matteelli, Alberto, et al.
Publicado: (2018)

Crop Improvement: Where Are We Now?
por: Sourdille, Pierre, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ad7k356uf3gd1gribt83o8rna7